Rational use of moxifloxacin for tuberculosis treatment

MSF Field Research > 1 Published Research and Commentary > TB > Rational use of moxifloxacin for tuberculosis treatment

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/129952
Del.icio.us LinkedIn Citeulike Connotea Facebook Stumble it!

View/Open	File	Description	Size	Format
Download this article:
View/Open	110401_Cox_Rational-Use-of-Moxifloxacin_Lancet-Infect-Dis-11-4-259-60.pdf	Main Article	40Kb	Adobe PDF

Title:	Rational use of moxifloxacin for tuberculosis treatment
Authors:	Cox, Helen Ford, Nathan Keshavjee, Salmaan McDermid, Cheryl von Schoen-Angerer, Tido Mitnick, Carole Goemaere, Eric
Affiliation:	Burnet Institute, Melbourne, Australia; Médecins Sans Frontières, Johannesburg, South Africa; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa; Harvard Medical School, Boston, USA; Partners in Health, Boston, USA; Médecins Sans Frontières Campaign for Access to Essential Medicines, Geneva, Switzerland
Citation:	Lancet Infect Dis 2011;11(4):259-60
Journal:	The Lancet Infectious Diseases
Issue Date:	1-Apr-2011
URI:	http://hdl.handle.net/10144/129952
DOI:	10.1016/S1473-3099(11)70036-6
PubMed ID:	21453864
Additional Links:	http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70036-6/fulltext?_eventId=login
Submitted date:	2011-04-29
Type:	Article
Language:	en
MeSH:	Tuberculosis Tuberculosis, Multidrug-Resistant Moxifloxacin
ISSN:	1474-4457
Rights:	Published by Elsevier Reproduced on this site with permission of Elsevier Ltd. Please see http://www.thelancet.com/journals/laninf for further relevant comment.
Appears in topics:	TB

Related articles on PubMed

Moxifloxacin for tuberculosis.
Singh KP, Brown M, Murphy ME, Gillespie SH
2012 Mar

Moxifloxacin for tuberculosis.
Mendel C, Springsklee M
2012 Mar

Jun 19, 2013

Browse